KC
BLFS icon

Kenfarb & Co’s BioLife Solutions BLFS Stock Holding History

Kenfarb & Co’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$69K Hold
5,000
– – 0.06% 134
2023
Q2 		$110K Hold
5,000
– – 0.1% 123
2023
Q1 		$109K Hold
5,000
– – 0.1% 124
2022
Q4 		$91K Hold
5,000
– – 0.08% 127
2022
Q3 		$114K Buy
+5,000
New +$107K 0.11% 117

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Kenfarb & Co's BLFS Position: Q3 2023 in Review

Kenfarb & Co held its BioLife Solutions (BLFS) position steady in Q3 2023 at 5,000 shares worth $69K. The position accounts for 0.06% of the portfolio, ranked #134.

Kenfarb & Co first reported a position in BLFS in Q3 2022 and has held it in 5 quarters since. The position peaked at $114K in Q3 2022. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • Kenfarb & Co held 5,000 shares of BioLife Solutions worth $69K as of Q3 2023.
  • Kenfarb & Co left its BioLife Solutions share count unchanged in Q3 2023.
  • BioLife Solutions made up 0.06% of Kenfarb & Co's portfolio in Q3 2023, its #134 holding.
  • Kenfarb & Co first reported a position in BioLife Solutions in Q3 2022 and has held it in 5 quarters since.
  • Kenfarb & Co's BioLife Solutions position peaked at $114K in Q3 2022.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.